Letrozole Bluefish (Letrozole)

Letrozole works by selectively and non‑steroidally blocking the aromatase enzyme (CYP19A1). This enzyme normally converts androgens into estrogens; inhibition leads to a marked reduction in circulating estrogen, depriving estrogen‑dependent cancer cells of a key growth signal.

The dose of Letrozole Bluefish is determined by the prescribing clinician based on the individual patient's condition, renal and hepatic function, and treatment goals. The prescriber will select the appropriate strength and dosing schedule according to current clinical guidelines.

Letrozole is classified as pregnancy category X, indicating it is contraindicated in pregnancy because of known teratogenic risk. It is also not recommended during breastfeeding, as it may pass into breast milk and affect the infant. Effective contraception is required for women of child‑bearing potential.

To order Letrozole Bluefish, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative to letrozole in postmenopausal breast cancer is tamoxifen, a selective estrogen receptor modulator. While tamoxifen blocks estrogen receptors, letrozole reduces estrogen production itself. Letrozole generally provides greater estrogen suppression and may offer improved disease‑free survival, but the safety profile and patient tolerance differ and should be evaluated individually.

Letrozole Bluefish tablets should be stored at ambient temperature below 25 °C. Keep them in the original packaging to protect from moisture and light, and ensure the container is tightly closed. Do not store in areas of high humidity or direct sunlight.

Letrozole Bluefish is administered orally as a tablet. The tablet should be swallowed whole with a glass of water, preferably at the same time each day to maintain consistent blood levels. Food does not significantly affect absorption, so it may be taken with or without meals.

Serious risks associated with letrozole include severe liver injury, osteoporosis‑related bone fractures, pulmonary embolism, myocardial infarction and rare anaphylactic reactions. Patients should be monitored for signs of liver dysfunction, bone pain, unexplained shortness of breath, chest pain or allergic symptoms, and appropriate medical attention should be sought promptly.

Letrozole Bluefish should not be used by pregnant women, individuals who are breastfeeding, premenopausal women without ovarian suppression, patients with severe hepatic impairment, or those with a known hypersensitivity to letrozole or any tablet excipients. Clinicians should also exercise caution in patients with a history of cardiovascular disease or thromboembolic events.